Triage Now: an Observational, Prospective Multimarker Study of Biomarkers in Patients Presenting With Chest Pain
Completed
- Conditions
- Acute Coronary SyndromeMyocardial Infarction
- Registration Number
- NCT00380094
- Lead Sponsor
- Abbott RDx Cardiometabolic
- Brief Summary
Study of diagnostic tests for heart attack for patients with chest pain.
- Detailed Description
Study of multiple biomarkers, including myeloperoxidase, in the evaluation of patients presenting with suspected acute coronary syndrome.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1500
Inclusion Criteria
- Chest pain and ACS in differential diagnosis
- Age> 18 years
- Ability to give informed consent
Exclusion Criteria
- Trauma
- Vulnerable populations
- Known inflammatory condition
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of myeloperoxidase are studied in NCT00380094 for acute coronary syndrome diagnosis?
How does the TRIAGE NOW trial compare multimarker panels to standard troponin testing in chest pain patients?
Which biomarkers in NCT00380094 improve risk stratification for myocardial infarction in acute coronary syndrome?
What adverse events were observed in chest pain biomarker studies by Abbott RDx Cardiometabolic?
How do myeloperoxidase and other biomarkers in NCT00380094 influence early triage decisions for suspected heart attack patients?
Trial Locations
- Locations (1)
University of Mainz
🇩🇪Mainz, Germany
University of Mainz🇩🇪Mainz, Germany